Skip to Main Content

Paper Details

Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma.
Front Oncol
14
2019
Author NameAffiliation
Raushan T KurmashevaGreehey Children's Cancer Research Institute
Raushan T KurmashevaThe University of Texas Health Science Center at San Antonio
  • 1 - 2

Datasets

Release 1.2